Medical Properties Trust, Inc. (MPT) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped MPT stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Medical Properties Trust, Inc. has showcased considerable strengths in its operations and strategic growth plans. The robust revenue growth and acquisitions signal a bullish long-term outlook, though risks stemming from macroeconomic factors and regulatory scrutiny must be monitored. Analysts provide upside potential, suggesting this REIT has room for appreciation. The saved 1-year distribution is P10 $4.25, P50 $6, and P90 $7.2.
Last analyzed · Model: gpt-4o
Medical Properties Trust, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $4.25 | Pessimistic plausible scenario |
| P50 | $6 | Median scenario |
| P90 | $7.2 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Medical Properties Trust shows strong revenue growth potential and has demonstrated operational improvements in recent quarters. However, its performance is tempered by risks associated with regulatory scrutiny and interest rate sensitivity. Analysts indicate a mean price target above the current valuation, suggesting upside potential.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this MPT analysis generated?
June 1, 2026.
Is this a guaranteed MPT prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full MPT stock analysis · MPT sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.